m6A demethylase FTO and osteoporosis: potential therapeutic interventions

Osteoporosis is a common bone disease, characterized by a descent in bone mass due to the dysregulation of bone homeostasis. Although different studies have identified an association between osteoporosis and epigenetic alterations in osteogenic genes, the mechanisms of osteoporosis remain unclear. N...

Full description

Bibliographic Details
Main Authors: Mei Huang, Jianmin Guo, Lifei Liu, Haiming Jin, Xi Chen, Jun Zou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2023.1275475/full
_version_ 1797629425048616960
author Mei Huang
Jianmin Guo
Lifei Liu
Lifei Liu
Haiming Jin
Xi Chen
Jun Zou
author_facet Mei Huang
Jianmin Guo
Lifei Liu
Lifei Liu
Haiming Jin
Xi Chen
Jun Zou
author_sort Mei Huang
collection DOAJ
description Osteoporosis is a common bone disease, characterized by a descent in bone mass due to the dysregulation of bone homeostasis. Although different studies have identified an association between osteoporosis and epigenetic alterations in osteogenic genes, the mechanisms of osteoporosis remain unclear. N6-methyladenosine (m6A) modification is a methylated adenosine nucleotide, which regulates the translocation, exporting, translation, and decay of RNA. FTO is the first identified m6A demethylase, which eliminates m6A modifications from RNAs. Variation in FTO disturbs m6A methylation in RNAs to regulate cell proliferation, differentiation, and apoptosis. Besides, FTO as an obesity-associated gene, also affects osteogenesis by regulating adipogenesis. Pharmacological inhibition of FTO markedly altered bone mass, bone mineral density and the distribution of adipose tissue. Small molecules which modulate FTO function are potentially novel remedies to the treatment of osteoporosis by adjusting the m6A levels. This article reviews the roles of m6A demethylase FTO in regulating bone metabolism and osteoporosis.
first_indexed 2024-03-11T10:54:10Z
format Article
id doaj.art-69b1cb801b764a94b985b8bfeb18a07e
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-03-11T10:54:10Z
publishDate 2023-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-69b1cb801b764a94b985b8bfeb18a07e2023-11-13T11:53:31ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2023-11-011110.3389/fcell.2023.12754751275475m6A demethylase FTO and osteoporosis: potential therapeutic interventionsMei Huang0Jianmin Guo1Lifei Liu2Lifei Liu3Haiming Jin4Xi Chen5Jun Zou6School of Kinesiology, Shanghai University of Sport, Shanghai, ChinaSchool of Kinesiology, Shanghai University of Sport, Shanghai, ChinaSchool of Kinesiology, Shanghai University of Sport, Shanghai, ChinaDepartment of Rehabilitation, The People’s Hospital of Liaoning Province, Shenyang, ChinaDepartment of Orthopaedics, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, ChinaSchool of Sports Science, Wenzhou Medical University, Wenzhou, ChinaSchool of Kinesiology, Shanghai University of Sport, Shanghai, ChinaOsteoporosis is a common bone disease, characterized by a descent in bone mass due to the dysregulation of bone homeostasis. Although different studies have identified an association between osteoporosis and epigenetic alterations in osteogenic genes, the mechanisms of osteoporosis remain unclear. N6-methyladenosine (m6A) modification is a methylated adenosine nucleotide, which regulates the translocation, exporting, translation, and decay of RNA. FTO is the first identified m6A demethylase, which eliminates m6A modifications from RNAs. Variation in FTO disturbs m6A methylation in RNAs to regulate cell proliferation, differentiation, and apoptosis. Besides, FTO as an obesity-associated gene, also affects osteogenesis by regulating adipogenesis. Pharmacological inhibition of FTO markedly altered bone mass, bone mineral density and the distribution of adipose tissue. Small molecules which modulate FTO function are potentially novel remedies to the treatment of osteoporosis by adjusting the m6A levels. This article reviews the roles of m6A demethylase FTO in regulating bone metabolism and osteoporosis.https://www.frontiersin.org/articles/10.3389/fcell.2023.1275475/fullFTOm6A methylationbone metabolismFTO inhibitorosteoporosis
spellingShingle Mei Huang
Jianmin Guo
Lifei Liu
Lifei Liu
Haiming Jin
Xi Chen
Jun Zou
m6A demethylase FTO and osteoporosis: potential therapeutic interventions
Frontiers in Cell and Developmental Biology
FTO
m6A methylation
bone metabolism
FTO inhibitor
osteoporosis
title m6A demethylase FTO and osteoporosis: potential therapeutic interventions
title_full m6A demethylase FTO and osteoporosis: potential therapeutic interventions
title_fullStr m6A demethylase FTO and osteoporosis: potential therapeutic interventions
title_full_unstemmed m6A demethylase FTO and osteoporosis: potential therapeutic interventions
title_short m6A demethylase FTO and osteoporosis: potential therapeutic interventions
title_sort m6a demethylase fto and osteoporosis potential therapeutic interventions
topic FTO
m6A methylation
bone metabolism
FTO inhibitor
osteoporosis
url https://www.frontiersin.org/articles/10.3389/fcell.2023.1275475/full
work_keys_str_mv AT meihuang m6ademethylaseftoandosteoporosispotentialtherapeuticinterventions
AT jianminguo m6ademethylaseftoandosteoporosispotentialtherapeuticinterventions
AT lifeiliu m6ademethylaseftoandosteoporosispotentialtherapeuticinterventions
AT lifeiliu m6ademethylaseftoandosteoporosispotentialtherapeuticinterventions
AT haimingjin m6ademethylaseftoandosteoporosispotentialtherapeuticinterventions
AT xichen m6ademethylaseftoandosteoporosispotentialtherapeuticinterventions
AT junzou m6ademethylaseftoandosteoporosispotentialtherapeuticinterventions